OraSure Technologies is a global leader in infectious disease diagnostics, and our unique infectious disease assays for HIV, HCV, Ebola, and influenza provide accurate and easy-to-administer testing methods to help healthcare practitioners easily identify infected people.
The first and only FDA approved and CLIA Waived point of care test for HCV that is also CE Marked. Our simple platform enables healthcare providers to deliver an accurate diagnosis in 20 minutes.
View OraQuick HCV Rapid Antibody Test »The OraQuick ADVANCE® Rapid HIV‑1/2 Antibody Test is FDA‑approved for use with oral fluid, fingerstick or venous whole blood and plasma and delivers results with laboratory accuracy in 20 minutes. CDC guidelines call for routine testing in all healthcare settings to identify all HIV positive people and connect them to care. This simple test is ideal for screening programs in public health and outreach settings, emergency departments, labor and delivery, laboratories and physician offices.
View Oraquick ADVANCE HIV-1/2 Rapid Antibody Test »The OraQuick® Ebola Rapid Antigen Test is designed to detect viral antigens in fingerstick and venous whole blood from patients presenting with signs and symptoms of Ebola infection in conjunction with epidemiological risk factors. It is also intended for use with cadaveric oral fluid collected from recently deceased individuals with epidemiological risk factors who are suspected to have died of EVD.
View OraQuick Ebola Rapid Antigen Test »An FDA-approvedin vitro rapid qualitative test for the detection and differentiation of influenza type A and type B. An easy nasal swab procedure provides accurate results in as little as 10 minutes.
View OraSure QuickFlu Rapid Flu A+B Test »OraSure® HIV-1 Oral Specimen Collection Device collects oral fluid, which contains antibodies. The simple 2-5 minute collection procedure is ideal for insurance testing and other non-medical settings. The OraSure® device is placed into a preservative and shipped to a lab where the sample will be screened for HIV-1 antibodies.
View OraSure HIV-1 Oral Specimen Collection Device »UrSure, a wholly-owned subsidiary of OraSure, offers diagnostic tests that measure adherence to HIV medications, including pre-exposure prophylaxis or PrEP, the daily medication to prevent HIV. This includes laboratory-based tests that can measure levels of the medication in a patient’s urine or blood, as well as several additional point of care products in development.
Continue to UrSureinc.com »